Invention Grant
- Patent Title: Substituted piperidine compound and use thereof
-
Application No.: US16075240Application Date: 2017-02-01
-
Publication No.: US10508083B2Publication Date: 2019-12-17
- Inventor: Tatsuhiko Fujimoto , Kentaro Rikimaru , Koichiro Fukuda , Hiromichi Sugimoto , Takahiro Matsumoto
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2016-019834 20160204
- International Application: PCT/JP2017/003610 WO 20170201
- International Announcement: WO2017/135306 WO 20170810
- Main IPC: C07D211/36
- IPC: C07D211/36 ; A61P25/00
Abstract:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
Public/Granted literature
- US20190031611A1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF Public/Granted day:2019-01-31
Information query
